Diabetic retinopathy affects nearly one-quarter of U.S. adults with diabetes, with an estimated 9.6 million people living with the disease and 1.84 million experiencing vision-threatening retinopathy. Because severe nonproliferative and proliferative disease, along with diabetic macular edema, can progress silently before vision loss becomes apparent, precise screening intervals, staging, and documentation are among the highest-value clinical actions a primary care team can take.
AAVBC's Diabetic Eye Disease Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across diabetes type, retinopathy severity, macular edema status, and laterality, HCC/RAF V28 mapping, type 1 versus type 2 screening intervals, disease staging and severity matrices, MEAT documentation standards, guideline-aligned treatment escalation by patient profile, comorbidity screening, and coding reminders with case examples. Grounded in current AAO Preferred Practice Pattern, ADA, and Endocrine Society guidance, this guide supports consistent, individualized clinical decision-making, helping care teams reregnize and stage diabetic eye disease accurately, document clinical complexity completely, and coordinate care with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of diabetic eye disease — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Diabetic retinopathy affects nearly one-quarter of U.S. adults with diabetes, with an estimated 9.6 million people living with the disease and 1.84 million experiencing vision-threatening retinopathy. Because severe nonproliferative and proliferative disease, along with diabetic macular edema, can progress silently before vision loss becomes apparent, precise screening intervals, staging, and documentation are among the highest-value clinical actions a primary care team can take.
AAVBC's Diabetic Eye Disease Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across diabetes type, retinopathy severity, macular edema status, and laterality, HCC/RAF V28 mapping, type 1 versus type 2 screening intervals, disease staging and severity matrices, MEAT documentation standards, guideline-aligned treatment escalation by patient profile, comorbidity screening, and coding reminders with case examples. Grounded in current AAO Preferred Practice Pattern, ADA, and Endocrine Society guidance, this guide supports consistent, individualized clinical decision-making, helping care teams reregnize and stage diabetic eye disease accurately, document clinical complexity completely, and coordinate care with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of diabetic eye disease — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
